Evidence map›Paper›PMID 41287934›Full record

ArticleDevelopment (Cambridge, England)2025

N2B27 media formulations influence gastruloid development.

Tina Balayo, Sharna Lunn, Pau Pascual-Mas, Ulla-Maj Fiuza, Amruta Vasudevan, Joshua D Frenster, Joel B Josende García, Hannah Y Galloon, Raquel Flores Peirats, Alfonso Martinez Arias and 2 more

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tina BalayoDepartment of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona 08003, Spain.ORCID 0000-0002-2185-6989
Sharna LunnInstitute of Life-Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L7 8TX, UK.ORCID 0000-0002-6497-6649
Pau Pascual-MasDepartment of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona 08003, Spain.ORCID 0000-0002-6873-6538
Ulla-Maj FiuzaDepartment of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona 08003, Spain.ORCID 0000-0002-8691-0325
Amruta VasudevanInstitute of Life-Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L7 8TX, UK.ORCID 0000-0002-5777-9508
Joshua D FrensterDepartment of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona 08003, Spain.ORCID 0000-0003-2401-1575
Joel B Josende GarcíaDepartment of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona 08003, Spain.ORCID 0009-0007-5442-7375
Hannah Y GalloonInstitute of Life-Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L7 8TX, UK.ORCID 0009-0007-7930-2130
Raquel Flores PeiratsDepartment of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona 08003, Spain.ORCID 0000-0002-5844-470X
Alfonso Martinez AriasDepartment of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona 08003, Spain.ORCID 0000-0002-1781-564X
André DiasDepartment of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona 08003, Spain.ORCID 0000-0003-3337-6373
David A TurnerInstitute of Life-Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L7 8TX, UK.ORCID 0000-0002-3447-7662

Funding

Biotechnology and Biological Sciences Research Council BB/X000907/1Biotechnology and Biological Sciences Research Council BB/Y00311X/1European Molecular Biology Organization ALTF 605-2022European Molecular Biology Organization ALTF 948-2022European Research Council'la Caixa' Foundation 100010434'la Caixa' Foundation LCF/BQ/PI23/11970017Ministerio de Ciencia, Innovación y Universidades CEX2018-000792-MNational Centre for the Replacement NC/T002131/1Refinement and Reduction of Animals in ResearchUniversity of Liverpool
6 · The paper itself

Abstract

Gastruloids are 3D aggregates of pluripotent stem cells grown in suspension culture that mimic many aspects of gastrulation and early axial elongation. The N2B27 basal medium in which mouse gastruloids are cultured can either be home-made (HM-N2B27) with materials of known origin, or commercially sourced (NDiff227), where the exact formulation is unknown. In this study, we examined whether these formulations resulted in significant differences in gastruloid development. Our results reveal that while both media enable standard gastruloid elongation, HM-N2B27 gastruloids initiate the elongation process earlier, have a higher number of cells and an increased anterior domain. Despite the maintenance of overall gene expression patterns, RNAseq analysis indicated differences in cell fate specification, with HM-N2B27 gastruloids exhibiting higher expression of spinal cord-related genes, while NDiff227 favours mesodermal differentiation. Furthermore, differential gene enrichment analysis suggests that changes in key signalling pathways underlie the differences between HM-N2B27 and NDiff227 gastruloids. These findings highlight the importance of basal media composition for gastruloid development, underscoring the need for careful media selection during in vitro engineering of stem cell-based embryo models.

Indexed as

Culture MediaGastrulaGastrulationOrganoidsAnimalsCell Culture TechniquesCell DifferentiationGene Expression Regulation, DevelopmentalMicePluripotent Stem CellsCulture MediaCell fateGastruloidsMouse embryonic stem cellsN2B27NDiff®227Signalling and gastrulation

Identifiers

PMID41287934
PMCPMC12687332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.